VERO — Venus Concept Inc.

VERO Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Total Revenue: $13.8 million, down 8% year-over-year.
• Energy-Based Devices (EBD) Revenue: $9.5 million, up 2% year-over-year.
• Gross Profit: $8.8 million, down 11% year-over-year; gross margin at 64%.
• Operating Loss: $9.5 million, compared to $7.2 million in Q3 2024.
• Net Loss: $22.6 million or $12.14 per share, compared to a net loss of $9.3 million or $13.1 per share in Q3 2024.
• Adjusted EBITDA Loss: $7.8 million, worsening from a loss of $5.9 million in Q3 2024.
• Cash and Cash Equivalents: $5.9 million; total debt obligations reduced to $30.1 million from $39.7 million at the end of 2024.

2. Strategic Updates and Business Highlights:

• Product Launch: Received 510 clearance for the Venus Nova, a multi-application platform aimed at redefining noninvasive treatments, expected to launch commercially in December 2025.
• Focus on Core Products: Strengthened sales efficiency in the U.S. market, particularly with BlissMax and VersaPro.
• Debt Management: Successful debt-to-equity exchanges totaling $11.5 million and increased financing capacity through amendments with Madryn Asset Management.
• Strategic Sale: Ongoing efforts to finalize the sale of the Venus Hair business to MHG Co. Ltd., with legal assistance sought to expedite the process.

3. Forward Guidance and Outlook:

• Fourth Quarter Expectations: Targeting sequential growth, bolstered by the limited launch of Venus Nova.
• Long-Term Growth: Anticipation of increased GLP-1 medication usage, which is expected to drive demand for complementary body technologies.
• No Full-Year Guidance: The company refrained from providing full-year 2025 financial guidance due to ongoing market uncertainties and strategic evaluations.

4. Bad News, Challenges, or Points of Concern:

• Revenue Decline: Total revenue decreased significantly, with a notable drop in the hair restoration segment due to economic pressures and financing challenges.
• Operational Losses: Increased operating losses and a substantial net loss raise concerns about profitability.
• Pending Sale Issues: Delays and challenges in closing the sale of the Venus Hair business could hinder strategic focus and financial stability.
• Market Conditions: Economic uncertainty, tight credit markets, and customer financing pressures continue to pose risks to robotic system adoption and overall sales.

5. Notable Q&A Insights:

• No questions were raised during the Q&A session, indicating either a lack of immediate investor concerns or a preference for further clarification through future communications.

Overall, while VERO demonstrated some positive developments in product innovation and debt management, it faces significant challenges in revenue generation and operational losses, necessitating careful navigation of its strategic initiatives moving forward.